NCT04717765 Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention Status COMPLETED Phase NA
NCT04713449 Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial Status ACTIVE_NOT_RECRUITING Phase NA
NCT04704466 Impact of Covid-19 Pandemic on Management of Head and Neck Cancers Status COMPLETED Phase N/A
NCT04704453 Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. Status COMPLETED Phase PHASE2
NCT04700475 Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients. Status UNKNOWN Phase NA
NCT04699487 Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy Status COMPLETED Phase NA
NCT04698499 Swallowing Therapy With the Assistance of a Mobile Health Device in Head and Neck Cancer Patients: a Pan-Alberta Study Status COMPLETED Phase NA
NCT04691310 The Efficacy of Kinesio Taping on Lymphedema Following Head and Neck Cancer Therapy Status COMPLETED Phase NA
NCT04690166 Validation of the Turkish Translation of the London Speech Evaluation Scale Status COMPLETED Phase N/A
NCT04682431 A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04675333 Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04675294 Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04671940 Exploratory Study of Clonal Evolution in Cancer for Patients Undergoing Transoral Robotic Surgery for Radiation Exposed Residual/reCurrent Tumours of the Upper Aerodigestive Tract Status RECRUITING Phase N/A
NCT04671862 Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis Status RECRUITING Phase NA
NCT04666688 LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04662554 Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging Status NOT_YET_RECRUITING Phase NA
NCT04660929 CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04640480 Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors Status COMPLETED Phase PHASE1
NCT04634825 Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer Status TERMINATED Phase PHASE2